The J&J vaccine is a single-dose treatment. Hence, researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the ...

At the moment only Pfizer/BioNTech's Comirnaty vaccine has been approved by the FDA for booster use, but a decision by the agency is expected in the coming days for the Moderna and J&J jabs.

The FDA has authorised booster shots with Moderna and Johnson & Johnson ... The situation is a little different for J&J’s Ad26.COV2.S vaccine, which is initially administered as one rather ...

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of mRNA-based pandemic influenza vaccines. The award was made ...

Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on messenger ribonucleic acid (mRNA) for the treatment of infectious ...

on popular weight loss therapies and psychedelic drugs in addition to his position and past remarks on vaccines. Meanwhile, U.S. Centers for Disease Control and Prevention employees have ...

The deal would help accelerate growth in J&J's drugs business after the company spun off its consumer health unit in 2023. It has made several transactions in the past few years to boost its ...

Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...

J&J's $132 per-share offer implies 39% premium Deal could kick off spree of activity in sector in 2025 CEO says such large deals not common The deal would help accelerate growth in J&J's drugs ...

Johnson & Johnson (NYSE:JNJ) fell ~3% in early trading on Wednesday, marking its biggest intraday drop since July 2023, even as the healthcare giant posted better-than-expected financials for Q4 ...